Literature DB >> 22943141

Protective effect of carnosine on subcortical ischemic vascular dementia in mice.

Jing Ma1, Jia-Yan Xiong, Wei-Wei Hou, Hai-Jing Yan, Yun Sun, Shang-Wei Huang, Le Jin, Ye Wang, Wei-Wei Hu, Zhong Chen.   

Abstract

AIMS: Recently, we found carnosine protects against N-Methyl-D-Aspartate (NMDA) induced excitotoxicity through a histaminergic pathway. The aim of this study was to determine whether the carnosine-histidine-histamine pathway also played a protective role in subcortical ischemic vascular dementia (SIVD).
METHODS: Adult male mice (C57BL/6 strain) were subjected to right unilateral common carotid arteries occlusion (rUCCAO) and treated with carnosine or histidine. Object recognition test, passive avoidance task, Morris water maze, and immunohistochemical analyses were performed after rUCCAO.
RESULTS: We found that carnosine (200, 500 mg/kg) ameliorated white matter lesion and cognitive impairment evaluated by object recognition test, passive avoidance task, and Morris water maze test after rUCCAO in both wide-type mice and histidine decarboxylase knockout mice, which are lack of endogenous histamine. However, administration of histidine did not show the same effect. The myelin basic protein in the corpus callosum decreased obviously at day 37 after rUCCAO, which was largely reversed by carnosine (200, 500 mg/kg). Carnosine (200, 500 mg/kg) suppressed the activation of microglia and astrocyte as attenuating the elevation of glial fibrillary acidic protein (GFAP) and Iba-1 fluorescent intensity. Moreover, carnosine (200, 500 mg/kg) significantly attenuated the increase in reactive oxygen species generation after rUCCAO.
CONCLUSION: These data suggest that the neuroprotective effect of carnosine on rUCCAO in mice is not dependent on the histaminergic pathway, but may be due to a suppression of reactive oxygen species generation, glia activation, and myelin degeneration.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22943141      PMCID: PMC6493405          DOI: 10.1111/j.1755-5949.2012.00362.x

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  34 in total

1.  Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke.

Authors:  Tauheed Ishrat; Abdelrahman Y Fouda; Bindu Pillai; Wael Eldahshan; Heba Ahmed; Jennifer L Waller; Adviye Ergul; Susan C Fagan
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-14       Impact factor: 6.200

2.  Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.

Authors:  Siamak Afshin-Majd; Mohsen Khalili; Mehrdad Roghani; Narges Mehranmehr; Tourandokht Baluchnejadmojarad
Journal:  Mol Neurobiol       Date:  2014-06-18       Impact factor: 5.590

3.  Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage.

Authors:  Seung-Hoon Baek; Ah Reum Noh; Kyeong-A Kim; Muhammad Akram; Young-Jun Shin; Eun-Sun Kim; Seong Woon Yu; Arshad Majid; Ok-Nam Bae
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

4.  Carnosine attenuates early brain injury through its antioxidative and anti-apoptotic effects in a rat experimental subarachnoid hemorrhage model.

Authors:  Zong-yong Zhang; Bao-liang Sun; Ming-feng Yang; Da-wei Li; Jie Fang; Shuai Zhang
Journal:  Cell Mol Neurobiol       Date:  2014-09-02       Impact factor: 5.046

Review 5.  Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition.

Authors:  Diewertje I Bink; Katja Ritz; Eleonora Aronica; Louise van der Weerd; Mat J A P Daemen
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

6.  Protective effect of carnosine after chronic cerebral hypoperfusion possibly through suppressing astrocyte activation.

Authors:  Jing Ma; Jihui Chen; Shuhong Bo; Xiaotong Lu; Jian Zhang
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

7.  High fat diet-induced diabetes in mice exacerbates cognitive deficit due to chronic hypoperfusion.

Authors:  Kristen L Zuloaga; Lance A Johnson; Natalie E Roese; Tessa Marzulla; Wenri Zhang; Xiao Nie; Farah N Alkayed; Christine Hong; Marjorie R Grafe; Martin M Pike; Jacob Raber; Nabil J Alkayed
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-11       Impact factor: 6.200

8.  Ketanserin improves cardiac performance after myocardial infarction in spontaneously hypertensive rats partially through restoration of baroreflex function.

Authors:  Jian-guang Yu; En-hui Zhang; Ai-jun Liu; Jian-guo Liu; Guo-jun Cai; Ding-feng Su
Journal:  Acta Pharmacol Sin       Date:  2013-11-18       Impact factor: 6.150

9.  Triptolide protects against white matter injury induced by chronic cerebral hypoperfusion in mice.

Authors:  Yu-Shan Wan; Yi You; Qian-Yun Ding; Yi-Xin Xu; Han Chen; Rong-Rong Wang; Yu-Wen Huang; Zhong Chen; Wei-Wei Hu; Lei Jiang
Journal:  Acta Pharmacol Sin       Date:  2021-04-06       Impact factor: 6.150

10.  Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial.

Authors:  Kirthi Menon; James D Cameron; Maximilian de Courten; Barbora de Courten
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.